“RNA Advisors has been my go-to valuation firm for all the companies I have built. In my new capacity as a VC, I would recommend RNA Advisors to all my portfolio companies. RNA staff is one of the industry’s most capable and collaborative experts.”
“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”
“I love the RNA team. They get healthcare and we’ve worked with the team both in valuation advisory capacities as well as on strategic projects for us as we take SmithRx to the next level. These guys get it!”
“RNA knows the diagnostics space. From Nanosphere to Biocartis, RNA has been my valuation firm of choice. They are responsive, efficient and I know that they’ll deliver. I’ve been glad to see their success and growth. It’s well deserved.”
Intelligence can create abundance. Only integration decides whether... [read more]
A companion to our peer-reviewed paper in JPMSA... [read more]
[Extended JPMSA article summary] The financial tools most... [read more]
Most founders and CEOs understand bad clients. A... [read more]
It’s Not Always Positive Ask a biotech CEO... [read more]
Unfortunately, this actually happened. I. The Worldview Before... [read more]
Why Biotech Executives and Investors Should Understand the... [read more]
Data-Driven Narrative for Capital Formation in Life Sciences... [read more]
Since 2015, RNA Advisors has provided valuation, transactional... [read more]
Enter your email address below to receive updates from RNA Advisors.
